Group One Trading
RYTM icon

Group One Trading’s Rhythm Pharmaceuticals RYTM Stock Holding History

Group One Trading’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,300
Closed -$246K – 8597
2025
Q4 		$246K Buy
2,300
+2,200
+2,200% +$233K ﹤0.01% 4192
2025
Q3 		$10.1K Hold
100
– – ﹤0.01% 7164
2025
Q2 		$6.32K Buy
+100
New +$6.12K ﹤0.01% 6979
2024
Q4 		– Sell
-6,000
Closed -$314K – 7872
2024
Q3 		$314K Sell
6,000
-7,500
-56% -$359K ﹤0.01% 3224
2024
Q2 		$554K Hold
13,500
– – ﹤0.01% 2472
2024
Q1 		$585K Buy
13,500
+12,500
+1,250% +$547K ﹤0.01% 2580
2023
Q4 		$46K Sell
1,000
-3,000
-75% -$94.6K ﹤0.01% 5128
2023
Q3 		$91.7K Buy
+4,000
New +$89.6K ﹤0.01% 4538
2023
Q2 		– Sell
-5,000
Closed -$89.2K – 8139
2023
Q1 		$89.2K Buy
5,000
+4,300
+614% +$108K ﹤0.01% 4395
2022
Q4 		$20.4K Buy
700
+200
+40% +$5.14K ﹤0.01% 5589
2022
Q3 		$12K Sell
500
-2,000
-80% -$37.2K ﹤0.01% 6385
2022
Q2 		$10K Sell
2,500
-500
-17% -$2.74K ﹤0.01% 6773
2022
Q1 		$35K Sell
3,000
-300
-9% -$2.63K ﹤0.01% 6378
2021
Q4 		$33K Buy
3,300
+300
+10% +$3.37K ﹤0.01% 6645
2021
Q3 		$39K Buy
3,000
+1,900
+173% +$29K ﹤0.01% 6739
2021
Q2 		$22K Sell
1,100
-400
-27% -$8.31K ﹤0.01% 7130
2021
Q1 		$32K Buy
1,500
+300
+25% +$8.7K ﹤0.01% 6508
2020
Q4 		$36K Buy
1,200
+600
+100% +$15.2K ﹤0.01% 5203
2020
Q3 		$13K Buy
+600
New +$13.8K ﹤0.01% 5324

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Group One Trading's RYTM Position: Q3 2024 in Review

Group One Trading sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2024, closing a stake of 4,991 shares — an estimated $239K sold.

Group One Trading first reported a position in RYTM in Q3 2020 and held it in 8 quarters. The position peaked at $205K in Q2 2024. 176 funds tracked by Wall St. Rank hold RYTM as of Q3 2024.

  • Group One Trading reported no remaining Rhythm Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 4,991 Rhythm Pharmaceuticals shares in Q3 2024, an estimated $239K.
  • Group One Trading first reported a position in Rhythm Pharmaceuticals in Q3 2020 and held it in 8 quarters.
  • Group One Trading's Rhythm Pharmaceuticals position peaked at $205K in Q2 2024.
  • 176 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.